Expansion / Replacement High Throughput Sequencing platform for WGS
Radboud Universitair Medisch Centrum (RUMC) is seeking a high-throughput sequencing platform for Whole Genome Sequencing (WGS) with an annual capacity of approximately 15,000 runs. The new sequencer must be compatible with Illumina and Twist Bioscience library kits without requiring additional conversion kits, ensuring that libraries can be seamlessly exchanged between the current platform and the new system. A Q40 performance of more than 50% is required, along with a built-in bioinformatics system for direct FastQ generation and the capability to support long-read sequencing. Additionally, commercial agreements must be established regarding the delivery and pricing of essential consumables to ensure the feasibility of WGS for diagnostic use.
Supplies · Onderhandeling zonder bekendmaking · European procedure
01What is being requested
Radboud Universitair Medisch Centrum (RUMC) is seeking a high-throughput sequencing platform for Whole Genome Sequencing (WGS) with an annual capacity of approximately 15,000 runs. The new sequencer must be compatible with Illumina and Twist Bioscience library kits without requiring additional conversion kits, ensuring that libraries can be seamlessly exchanged between the current platform and the new system. A Q40 performance of more than 50% is required, along with a built-in bioinformatics system for direct FastQ generation and the capability to support long-read sequencing. Additionally, commercial agreements must be established regarding the delivery and pricing of essential consumables to ensure the feasibility of WGS for diagnostic use.
Purchase of a high-capacity and flexible sequencer, including maintenance and support, which can at least meet the following properties: - Platform capacity of ±15,000 WGS per year - Compatibility with Illumina, Twist Bioscience, and other commercially available library prep kits without the use of conversion kits. - Libraries must be interchangeable between the current sequencing platforms and the sequencing platform to be delivered without modifications. - Officially described Q40 values where >50% Q40. - An onboard bioinformatics system for conversion to FastQ files. - Possibility to use t
02Exclusion grounds
- No specific exclusion grounds were extracted. In a European tender, the mandatory and discretionary grounds of art. 2.86/2.87 of the Dutch Procurement Act almost always apply — check the European Single Procurement Document (ESPD).
03Value in context
The contracting authority did not publish an estimated value — common for a large share of contracts. The EU threshold for leveringen is € 221.000, for reference.
04Likely competitors
05Legal themes that may be relevant here
06Frequently asked questions
What technical capacity must the sequencing platform meet?
What requirements are set for the quality of the sequencing (Q40)?
Which library prep kits must the system be compatible with?
Is the platform suitable for long-read sequencing?
What bioinformatics functionality is required?
Automatically compiled from the official tender data and documents.
07Estimated value versus the market
€ 300K
€ 515K
€ 1,7 mln
Gegunde waarden in CPV 38 · leveringen n=331